Plozasiran, an RNA Interference agent targeting APOC3, for mixed hyperlipidemia
Ballantyne CM, Vasas S, Azizad M, et al.
N Engl J Med. Pub. Online 28 May 2024.
Leggi
Ballantyne CM, Vasas S, Azizad M, et al.
N Engl J Med. Pub. Online 28 May 2024.
Leggi
Hebeisen I, Gonzalez Rodriguez E, Arhab A, et al.
BMJ Open Diabetes Res Care. Pub. Online 21 May 2024.
Leggi
Salvatori B, Wegener S, Kotzaeridi G, et al.
Diabetologia. Pub. Online 27 May 2024.
Leggi
Andrews C, Maya J, Schulte CCM, et al.
Diabetes Care. Pub. Online 24 May 2024.
Leggi
Riester MR, Zullo AR, Joshi R, et al.
Diabetes Obes Metab. Pub. Online 23 May 2024.
Leggi
De Meulemeester J, Charleer S, Visser MM, et al.
Diabetologia. Pub. Online 24 May 2024.
Leggi
Laddu D, Neeland IJ, Carnethon M, et al.
Circulation. Pub. Online 20 May 2024.
Leggi
Boeder SC, Thomas RL, Le Roux MJ, et al.
Diabetes Care. Pub. online 22 May 2024.
Leggi
Koefoed AS, Knorr S, Fuglsang J, et al.
Diabetes Care. Pub. online 21 May 2024.
Leggi
Yang X, Wang G, Liu N, et al.
BMC Pregnancy Childbirth. Pub. online 22 May 2024.
Leggi